CHEBI:88707 - DG(14:1(9Z)/24:0/0:0)

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name DG(14:1(9Z)/24:0/0:0) ChEBI ID CHEBI:88707 Stars This entity has been manually annotated by a third party. Supplier Information ZINC000040164651 Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C41H78O5 Net Charge 0 Average Mass 651.057 Monoisotopic Mass 650.58493 InChI InChI=1S/C41H78O5/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-26-28-30-32-34-36-41(44)46-39(37-42)38-45-40(43)35-33-31-29-27-25-14-12-10-8-6-4-2/h10,12,39,42H,3-9,11,13-38H2,1-2H3/b12-10-/t39-/m0/s1 InChIKey UTZGYUJNAHEZNG-BAFOCXNNSA-N SMILES C([C@@](COC(CCCCCCC/C=C\CCCC)=O)(OC(CCCCCCCCCCCCCCCCCCCCCCC)=O)[H])O Metabolite of Species Details Homo sapiens (NCBI:txid9606) Found in blood (UBERON:0000178). See: PubMed Roles Classification Biological Role(s): Saccharomyces cerevisiae metabolite Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ). (via diglyceride ) human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). (via diglyceride ) View more via ChEBI Ontology ChEBI Ontology Outgoing DG(14:1(9Z)/24:0/0:0) (CHEBI:88707) is a diglyceride (CHEBI:18035) Synonyms Sources (2S)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl tetracosanoate HMDB 1-Myristoleoyl-2-lignoceroyl-sn-glycerol HMDB DAG(14:1/24:0) HMDB DAG(14:1n5/24:0) HMDB DAG(14:1w5/24:0) HMDB DAG(38:1) HMDB DG(14:1/24:0) HMDB DG(14:1n5/24:0) HMDB DG(14:1w5/24:0) HMDB DG(38:1) HMDB Diacylglycerol HMDB Diacylglycerol(14:1/24:0) HMDB Diacylglycerol(14:1n5/24:0) HMDB Diacylglycerol(14:1w5/24:0) HMDB Diacylglycerol(38:1) HMDB Diglyceride HMDB Manual Xref Database HMDB0007064 HMDB View more database links Citation Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, Bandyopadhyay S, Jones KN, Kelly S, Shaner RL, Sullards CM, Wang E, Murphy RC, Barkley RM, Leiker TJ, Raetz CR, Guan Z, Laird GM, Six DA, Russell DW, McDonald JG, Subramaniam S, Fahy E, Dennis EA (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. Journal of lipid research 51, 3299-3305 [PubMed:20671299] [show Abstract] The focus of the present study was to define the human plasma lipidome and to establish novel analytical methodologies to quantify the large spectrum of plasma lipids. Partial lipid analysis is now a regular part of every patient's blood test and physicians readily and regularly prescribe drugs that alter the levels of major plasma lipids such as cholesterol and triglycerides. Plasma contains many thousands of distinct lipid molecular species that fall into six main categories including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterols, and prenols. The physiological contributions of these diverse lipids and how their levels change in response to therapy remain largely unknown. As a first step toward answering these questions, we provide herein an in-depth lipidomics analysis of a pooled human plasma obtained from healthy individuals after overnight fasting and with a gender balance and an ethnic distribution that is representative of the US population. In total, we quantitatively assessed the levels of over 500 distinct molecular species distributed among the main lipid categories. As more information is obtained regarding the roles of individual lipids in health and disease, it seems likely that future blood tests will include an ever increasing number of these lipid molecules.